Replimune Group Statistics
Total Valuation
Replimune Group has a market cap or net worth of $1.67 billion. The enterprise value is $1.49 billion.
| Market Cap | 1.67B |
| Enterprise Value | 1.49B |
Important Dates
The last earnings date was Wednesday, October 28, 2026, before market open.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Replimune Group has 94.80 million shares outstanding. The number of shares has increased by 8.94% in one year.
| Current Share Class | 94.80M |
| Shares Outstanding | 94.80M |
| Shares Change (YoY) | +8.94% |
| Shares Change (QoQ) | +8.58% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 77.25% |
| Float | 68.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 19.13 |
| PB Ratio | 8.15 |
| P/TBV Ratio | 8.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.11, with a Debt / Equity ratio of 0.62.
| Current Ratio | 7.11 |
| Quick Ratio | 6.76 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.47 |
Financial Efficiency
Return on equity (ROE) is -115.80% and return on invested capital (ROIC) is -49.95%.
| Return on Equity (ROE) | -115.80% |
| Return on Assets (ROA) | -43.95% |
| Return on Invested Capital (ROIC) | -49.95% |
| Return on Capital Employed (ROCE) | -81.73% |
| Weighted Average Cost of Capital (WACC) | 9.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$582,869 |
| Employee Count | 465 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -551,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.48% in the last 52 weeks. The beta is 0.94, so Replimune Group's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +72.48% |
| 50-Day Moving Average | 13.58 |
| 200-Day Moving Average | 9.31 |
| Relative Strength Index (RSI) | 75.09 |
| Average Volume (20 Days) | 2,485,975 |
Short Selling Information
The latest short interest is 23.17 million, so 24.44% of the outstanding shares have been sold short.
| Short Interest | 23.17M |
| Short Previous Month | 23.13M |
| Short % of Shares Out | 24.44% |
| Short % of Float | 33.95% |
| Short Ratio (days to cover) | 11.50 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -268.39M |
| Pretax Income | -271.59M |
| Net Income | -271.03M |
| EBITDA | -262.64M |
| EBIT | -268.39M |
| Earnings Per Share (EPS) | -$2.78 |
Balance Sheet
The company has $307.83 million in cash and $127.19 million in debt, with a net cash position of $180.64 million or $1.91 per share.
| Cash & Cash Equivalents | 307.83M |
| Total Debt | 127.19M |
| Net Cash | 180.64M |
| Net Cash Per Share | $1.91 |
| Equity (Book Value) | 204.78M |
| Book Value Per Share | 2.16 |
| Working Capital | 278.48M |
Cash Flow
In the last 12 months, operating cash flow was -$245.55 million and capital expenditures -$223,000, giving a free cash flow of -$245.77 million.
| Operating Cash Flow | -245.55M |
| Capital Expenditures | -223,000 |
| Depreciation & Amortization | 5.76M |
| Net Borrowing | 49.19M |
| Free Cash Flow | -245.77M |
| FCF Per Share | -$2.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Replimune Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.94% |
| Shareholder Yield | -8.94% |
| Earnings Yield | -15.79% |
| FCF Yield | -14.72% |
Analyst Forecast
The average price target for Replimune Group is $23.33, which is 32.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $23.33 |
| Price Target Difference | 32.48% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |